Evidence map›Paper›PMID 35856489›Full record

ArticleJournal of managed care & specialty pharmacy2022

Economic outcomes of antiobesity medication use among adults in the United States: A retrospective cohort study.

Stephanie Watkins, Joshua C Toliver, Nina Kim, Sarah Whitmire, W Timothy Garvey

Open access · bronzeAbstract read
In one paragraph

Article in Journal of managed care & specialty pharmacy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Setting Expectations When Prescribing Medication for the Treatment of Patients With Obesity.Mayo Clinic proceedings. Innovations, quality & outcomes · 2025
    Review
  5. The association of weight loss from anti-obesity medications or bariatric surgery and apnea-hypopnea index in obstructive sleep apnea.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Stephanie WatkinsNovo Nordisk Inc, Plainsboro, NJ.
Joshua C ToliverNovo Nordisk Inc, Plainsboro, NJ.
Nina KimNovo Nordisk Inc, Plainsboro, NJ.
Sarah WhitmireNovo Nordisk Inc, Plainsboro, NJ.
W Timothy GarveyDepartment of Nutrition Sciences, University of Alabama at Birmingham.
Novo Nordisk (United States) · USUniversity of Alabama at Birmingham · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Obesity AgentsDrug CostsHealth Care CostsObesityAdultHumansMaleRetrospective StudiesUnited StatesAnti-Obesity Agents

Identifiers

PMID35856489
PMCPMC12101569
OpenAlexW4286211731

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.